Skip to main content
Log in

Pathophysiologie der Akne

Pathophysiology of acne

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Pathogenetisch sind bei der Entstehung der Akne verschiedene Faktoren von Bedeutung, unter anderem Seborrhö, follikuläre Hyperkeratose, Propionibakterien und entzündliche Vorgänge. Diese Übersichtsarbeit erläutert pathophysiologisch relevante Faktoren.

Abstract

Several pathogenic factors contribute to the development of acne, among them, seborrhea, follicular hyperkeratosis, propionibacteria, and inflammatory events. This article reviews current knowledge of these pathogenic factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Allaker RP, Greenman J, Osborne RH (1987) The production of inflammatory compounds by Propionibacterium acnes and other skin organisms. Br J Dermatol 117:175–183

    PubMed  Google Scholar 

  2. Choudhry R, Hodgins MB, Van der Kwast TH et al. (1992) Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 133:467–475

    PubMed  Google Scholar 

  3. Cunliffe WJ, Gollnick HPM (2004) Akne, Pathophysiologie, Klinik, Diagnose und Therapie. Dunitz, London

  4. Cunliffe WJ, Holland DB, Clark SM, Stables GI (2000) Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 142:1084–1091

    Article  PubMed  Google Scholar 

  5. De Young LM, Young JM, Ballaron SJ et al. (1984) Intradermal injection of Propionibacterium acnes: a model of inflammation relevant to acne. J Invest Dermatol 83:394–398

    Article  PubMed  Google Scholar 

  6. Gollnick H, Cunliffe W, Berson D et al. (2003) Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 49:S1–37

    Article  PubMed  Google Scholar 

  7. Graham GM, Farrar MD, Cruse-Sawyer JE et al. (2004) Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol 150:421–428

    Article  PubMed  Google Scholar 

  8. Guy R, Kealey T (1998) Modelling the infundibulum in acne. Dermatology 196:32–37

    Article  PubMed  Google Scholar 

  9. Guy R, Ridden C, Kealey T (1996) The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red. J Invest Dermatol 106:454–460

    Article  PubMed  Google Scholar 

  10. Ingham E, Eady EA, Goodwin CE et al. (1992) Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 98:895–901

    Article  PubMed  Google Scholar 

  11. Jappe U (2003) Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm Venereol 83:241–248

    Article  PubMed  Google Scholar 

  12. Jappe U, Ingham E, Henwood J, Holland KT (2002) Propionibacterium acnes and inflammation in acne; P. acnes has T-cell mitogenic activity. Br J Dermatol 146:202–209

    Article  PubMed  Google Scholar 

  13. Jeremy AH, Holland DB, Roberts SG et al. (2003) Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 121:20–27

    Article  PubMed  Google Scholar 

  14. Kim J, Ochoa MT, Krutzik SR et al. (2002) Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169:1535–1541

    PubMed  Google Scholar 

  15. Kirschbaum JO, Kligman AM (1963) The pathogenic role of corynebacterium acnes in acne vulgaris. Arch Dermatol 88:832–833

    PubMed  Google Scholar 

  16. Knor T (2005) The pathogenesis of acne. Acta Dermatovenerol Croat 13:44–49

    PubMed  Google Scholar 

  17. Leyden J, Bergfeld W, Drake L et al. (2004) A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. J Am Acad Dermatol 50:443–447

    Article  PubMed  Google Scholar 

  18. Leyden JJ (1995) New understandings of the pathogenesis of acne. J Am Acad Dermatol 32:S15–25

    Article  PubMed  Google Scholar 

  19. Leyden JJ, McGinley KJ, Mills OH, Kligman AM (1975) Age-related changes in the resident bacterial flora of the human face. J Invest Dermatol 65:379–381

    Article  PubMed  Google Scholar 

  20. Leyden JJ, McGinley KJ, Mills OH, Kligman AM (1975) Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 65:382–384

    Article  PubMed  Google Scholar 

  21. Lucky AW (1995) Hormonal correlates of acne and hirsutism. Am J Med 98:89S–94S

    Article  PubMed  Google Scholar 

  22. McInturff JE, Kim J (2005) The role of toll-like receptors in the pathophysiology of acne. Semin Cutan Med Surg 24:73–78

    Article  PubMed  Google Scholar 

  23. Mempel M, Voelcker V, Kollisch G et al. (2003) Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 121:1389–1396

    Article  PubMed  Google Scholar 

  24. Norris JF, Cunliffe WJ (1988) A histological and immunocytochemical study of early acne lesions. Br J Dermatol 118:651–659

    PubMed  Google Scholar 

  25. Plewig G, Kligman AM (2000) Acne and Rosacea. 3rd ed. Springer, Berlin

  26. Schaller M, Loewenstein M, Borelli C et al. (2005) Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III. Br J Dermatol 153:66–71

    Article  PubMed  Google Scholar 

  27. Thiboutot D, Chen W (2003) Update and future of hormonal therapy in acne. Dermatology 206:57–67

    Article  PubMed  Google Scholar 

  28. Vowels BR, Yang S, Leyden JJ (1995) Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 63:3158–3165

    PubMed  Google Scholar 

  29. Webster GF (1998) Inflammatory acne represents hypersensitivity to Propionibacterium acnes. Dermatology 196:80–81

    Article  PubMed  Google Scholar 

  30. Webster GF, Kligman AM (1979) A method for the assay of inflammatory mediators in follicular casts. J Invest Dermatol 73:266–268

    Article  PubMed  Google Scholar 

  31. Webster GF, Leyden JJ, Norman ME, Nilsson UR (1978) Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun 22:523–529

    PubMed  Google Scholar 

  32. Zouboulis CC, Nestoris S, Adler YD, Orth M, Orfanos CE, Picardo M, Camera E, Cunliffe WJ (2003) A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 139:668–670

    Article  PubMed  Google Scholar 

  33. Zouboulis Ch C, Saborowski A, Boschnakow A (2005) Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 210:36–38

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Degitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borelli, C., Plewig, G. & Degitz, K. Pathophysiologie der Akne. Hautarzt 56, 1013–1017 (2005). https://doi.org/10.1007/s00105-005-1043-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-005-1043-1

Schlüsselwörter

Keywords

Navigation